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ABSTRACT 
Objective: To study the effects of TiO2 nanoparticles in mice and explore the biological safety of TiO2 nanoparticles. Methods: The 
biological safety of TiO2 nanoparticles based on the oxidative stress pathway is investigated. One hundred mice were randomly 
divided into 10 groups. A low medium and high concentration experimental group and negative and positive control groups were 
investigated for both the intravenous injection and tracheal injection exposure experiments. Mice were observed for any symptoms, 
and the serum and lung homogenate for activity of SOD and content of MDA in serum and lung tissue were prepared. The scores of 
the allergic reaction determined the degree of anti-oxidation and the comprehensive experimental data determined the degree of 
injury in the mice. Results: An increase of TiO2 concentration in the nanomaterials led to a decrease of the content of MDA in serum 
and lung tissue of mice and the activity of SOD increased, indicating that mice showed oxidative stress in vivo. Conclusion: The 
strong direct exposure to a high concentration of TiO2 nanoparticles was harmful to the organism.
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1. INTRODUCTION 
The superior properties of nanomaterials have enabled 
nanotechnology to rapidly become a frontier field in 
science and technology. Among these materials, 
titanium dioxide (TiO2) is a material with great practical 
prospects, and it has been widely used in industry, 
agriculture, and other fields 
[1-3]
. The long-term exposure 
of humans to nanoscale materials in the workplace has 
increased the probability of its entry into the body
 [4-5]
. 
Although the research on the safety of titanium dioxide 
is continuously increasing, the depth and 
comprehensiveness of this knowledge still need to be 
improved.  
In this study, tail vein and tracheal exposure to various 
doses of TiO2 nanoparticles were administered to mice. 
The biosafety of nanoparticle titania, based on the 
oxidative stress pathway, was determined by observing 
the allergic reaction in mice and detecting the contents 
of MDA and SOD in the blood and lung tissues after 
administration of the TiO2 nanoparticles. 
2. EXPERIMENTAL MATERIALS AND 
METHODS 
2.1 Experimental animals 
Mice, KM species, male, weighing 20 ± 2 g. 
2.2 Experimental materials 
Samples were prepared by mixing 11.5 mg, 5.0 mg and 
0.9 mg of titanium oxide nanopowder (20 nm, purchased 
from EVONIK) with 115 mL, 100 mL and 90 mL of 
distilled water, respectively. Then, ultrasonication of the 
samples for one hour resulted in 0.1 mg/mL, 0.05 
mg/mL and 0.01 mg/mL titanium dioxide mixed 
solutions for the tail vein (Group 1 to Group 3). 
Tween-80 (0.5 mL) was mixed with distilled water (50 
mL) to result in a 1% Tween-80 as the fourth group for 
the positive control group, and the fifth group was the 
negative control group with distilled water. Titanium 
dioxide samples of 0.2 mg/kg, 1 mg/kg, and 2 mg/kg 
were used in the tracheal tube for exposure to the trachea 
(group 7 to group 9). The test was carried out by using 
50 mg, 25 mg and 5 mg of titanium dioxide powder, 
respectively, and 50 mL of distilled water. Tween-80 
(0.5 mL) was mixed with distilled water (50 mL) to 
make 1% Tween-80 for the positive control as the tenth 
group. Distilled water was used for the sixth group as the 
negative control group. An SOD kit and MDA kit were 
provided by Nanjing Jiancheng Bioengineering Research 
Institute. A BCA protein concentration determination kit 
was provided by the Beijing-cable Technology Co. The 
lung tissue homogenate was prepared according to the 
BCA Protein Concentration Assay Kit. Three different 
dilution concentrations were pre-tested. The 
concentration of protein in each lung tissue sample was 
determined by choosing the most appropriate dilution 
factor for the correlation and absorbance. 
 
Figure 1: TEM detection results of TiO2 
2.3 Experimental Method 
2.3.1 Groups of animals 
The mice were divided into 10 groups, with each group 
including 10 mice. 
Tail vein exposure: In the first, second and the third 
experimental groups, the dose was respectively 0.1 
mg/mL, 0.05 mg/mL and 0.01 mg/mL. The fourth group 
was the positive control group, and the fifth group was 
the negative control group. 
Tracheal exposure: the sixth group was the negative 
control group. The seventh, eighth and ninth 
experimental groups had the respective doses of 0.2 
mg/kg, 1 mg/kg and 2 mg/kg. The tenth group was the 
positive control group. 
2.3.2 Preparation of experimental drugs 
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1. Tail vein exposure of the experimental drug 
preparation (groups 1 to 5) was as follows: 
First, the TiO2 was characterised. The titanium dioxide 
powder (11.5 mg, 5.0 mg and 0.9 mg) was weighed 
using an analytical balance, and distilled water (115 mL, 
100 mL and 90 mL, respectively) was added to prepare 
the samples. Ultrasonication of the samples was 
performed for half-an-hour after mixing. The mixed 
solutions of 0.1 mg/mL, 0.05 mg/mL and 0.01 mg/mL of 
titanium dioxide were prepared as the experimental 
groups. On the other hand, measure the temperature -80 
0.5mL and distilled water 50mL,and mixed them. A 
mixed solution of 1% Tween-80 was prepared as the 
positive control group and distilled water was used for 
the negative control group.  
2. Tracheal exposure of the experimental drug 
preparation (groups 6 to 10) was as follows: 
Titanium dioxide powder (50 mg, 25 mg, 5 mg) was 
weighed using an analytical balance, then distilled water 
(50 mL) was added to prepare the samples. 
Ultrasonication of the samples was performed for 
half-an-hour after mixing, and the mixed solutions of 0.2 
mg/kg, 1 mg /kg and 2 mg/kg of titanium dioxide were 
prepared as the experimental groups. On the other hand, 
measure the temperature -80 1mL and distilled water 
50mL, and mixed them. A mixed solution of 2% 
Tween-80 was prepared as the positive control group 
and distilled water was used for the negative control 
group. Other samples were prepared according to the kit 
instructions. 
2.3.3 Administration 
1. Intravenous injection into the mice tail was performed 
with an injection dose of 0.1 mL/10 g. The first, second 
and third groups were respectively injected with 0.1 
mg/mL, 0.05 mg/mL, 0.01 mg/mL of the titanium 
dioxide solution, the fourth group was injected with 1% 
Tween-80, and the fifth group was injected with distilled 
water. 
2. Mice were anaesthetized with 1% sodium 
pentobarbital with a dose of 1 g/mL. After anaesthesia, 
the trachea was injected with the drug with a dose of 1 
µL/g. The seventh, eighth and ninth groups were 
respectively injected with 0.2 mg/kg, 1 mg/kg, 2 mg/kg 
of titanium dioxide solution, the twelfth group was 
injected with 2% Tween-80. The wound was sutured 
after administration. 
2.3.4 Detection of allergic reactions: 
The response of the selected experimental group within 
half-an-hour of administration was scored according to 
the allergic response score, as shown in Table 1, and the 
allergic response grade was determined, as shown in 
Table 2. 
2.3.5 Blood biochemical tests: 
After 24 hours from administration, 1% sodium 
pentobarbital was injected into the abdominal cavity 
with a dose of 0.8 mL/g. Blood was collected from the 
eyeballs of the mice after anaesthesia, and then 
centrifuged at 3000 rpm for 15 minutes. The supernatant 
was extracted, and the contents of SOD and MDA in the 
serum were determined in strict accordance with the kit 
instructions. 
2.3.6 Detection of lung biochemical tests: 
The lung tissue homogenate was prepared after blood 
sampling. The mouse chest was opened and lung tissue 
was removed and blot dried after rinsing the remaining 
blood with ice saline. The ice saline was used to prepare 
a 10% mixture. The tissue homogenate was mixed using 
an electric homogenizer and centrifuged to obtain the 
supernatant, and the contents of SOD and MDA in 
serum were determined in strict accordance with the kit 
instructions. 
Determination of the protein concentration in lung tissue 
sample was performed by taking the configured lung 
tissue homogenate. First, three different dilution 
pre-experiments were carried out according to the BCA 
protein concentration determination kit instructions. 
Then, selection of the correlation and absorbance of the 
most appropriate dilution factor for the formal 
experiment to determine the protein concentration of 
each lung tissue samples was performed. 
2.4 Statistical method: 
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The results were expressed as mean ± standard deviation 
(± S). SPSS 19.0 software was used to analyse the 
differences among the groups. Statistical analysis was 
performed by the t-test, and the difference was 
statistically significant as P <0.05.
  
Table 1 Symptoms of allergic reactions 
0 Normal 7  Shortness of breath 14  Gait instability 
1 Restlessness 8  urination 15  jump 
2 Vertical hair 9  Defecation 16  respite 
3   Trembling 10  Tears 17  Spasm 
4 Scratch the nose 11  Difficulty breathing 18  Rotate 
5 sneeze 12  Wheeze 19   Tidal breathing 
6 cough 13  Purpura 20  death 
 
Table 2: Systemic sensitisation evaluation criteria 
0 - Allergic reactions were negative 
1-4 symptom + Allergic reaction weakly positive 
5-10 symptom ++ Allergic reactions were positive 
11-19 symptom +++ Allergic reactions strongly positive 
20 ++++ Allergic reaction strongly positive 
 
3. EXPERIMENTAL RESULTS 
3.1 Allergy test results 
Allergic sensitivities of the first group to the fifth group 
were determined according to the degree of 
hypersensitivity: strong positive (+++), positive (++), 
weak positive (+) and negative (-) statistics. The results 
are shown in Table 3. The first, second and fourth 
groups showed a 100% positive rate, the third group 
showed a 70% positive rate, and the fifth group showed 
a 20% positive rate.
 
Table 3: Comparison of allergic reactions in different groups of mice  
Group Degree of allergic reaction  
Strong positive +++ Positive ++ Weakly positive + negative - Positive rate 
First group 3 7   100% 
Second Group 2 3 5  100% 
Third group  1 6 3 70% 
Fourth group 5 3 2  100% 
Fifth group   2 8 20% 
 
The first group and the fifth group were tested by 
Fisher’s exact test, with P=0.007, which was statistically 
significant. The difference between the second and fifth 
groups was statistically significant (P=0.019) by 
Fisher’s exact test. There was no significant difference 
between the third group and the fifth group for the 
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Fisher’s exact test (P=0.138). The difference between 
the fourth and fifth groups was statistically significant 
(P=0.005). 
3.2 Blood biochemical indicators test results 
3.2.1 Tracheal exposure test 
3.2.1.1 In serum: 
Total serum SOD activity = (OD value of the control − 
determination of OD) ÷ OD value of the control ÷ 50 × 
dilution of the reaction system × Sample dilution before 
the test. 
MDA content in serum = (OD value − OD value) ÷ 
(standard OD value − blank OD value) × standard 
concentration × sample dilution before the test. 
3.2.1.2 In lung tissue: 
Total lung tissue SOD activity = (OD value of the 
control − determination of OD) ÷ OD value of the 
control ÷ 50 × dilution of the reaction system × Sample 
dilution before the test. 
MDA content in lung tissue = (OD value − OD value) ÷ 
(standard OD value − blank OD value) × standard 
concentration × sample dilution before the test 
3.2.2 Tail vein exposure 
1. total SOD activity = (OD value of the control − 
determination of OD) ÷ OD value of the control ÷ 50 × 
dilution of the reaction system × sample dilution before 
the test 
2. MDA content = (OD value - OD value) ÷ (standard 
OD value - blank OD value) × standard concentration × 
sample dilution before the test. 
3.3 Lung biochemical tests 
1. The SOD (U / mL) activity of each group was 
calculated by the absorbance A of the serum measured 
at 550 nm and the protein concentration of the lung 
tissue sample using the SOD reagent kit. 
Animal tissue homogenate total SOD activity = (OD 
value of the control − measured OD value) ÷ 50% × 
(total volume of the reaction sample ÷ sample) ÷ sample 
protein concentration to be tested. 
2. The absorbance of lung tissue measured at 532 nm 
and the protein concentration of lung tissue and the 
content of MDA (nmoL/mg protein) in each group were 
measured by the MDA kit. Results are shown in Table 
4. 
MDA content in tissues = (OD value − OD value) ÷ 
(OD value − OD value) × Concentration of standard 
sample ÷ Sample protein concentration. 
3.4 Experimental oxidative stress levelling
 
Table 4 Comparison of allergic reactions in different groups of mice (first to fifth groups of mice as the test items) 
 
 
Group Number of mice SOD（u/ml） MDA(nmol/ml) 
First group（0.1mg/ml） 10 113.79±26.97 10.68±3.80 
Second Group (0.05mg/ml) 10 123.40±28.59 9.55±2.18 
The third group (0.01mg/ml) 10 168.40±30.17 9.32±1.66 
The fourth group (Negative control group) 10 88.63±37.11 10.75±3.36 
Fifth group（Positive control group） 10 173.62±39.32 9.34±2.44 
P  P<0.05 P>0.05 
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Table 5 Comparison of allergic reactions in different groups of mice 
(first to fifth groups of mice as the test items) 
 
To summarise the data analysis and results for the 
oxidative damage induced by TiO2 in mice, the SOD 
activity of serum in the first, second and third groups 
were significantly different from those in the fourth 
group (positive control group) and the fifth group 
(negative control group), P <0.05. 
In addition, for the tracheal exposure test, the activity of 
SOD decreased, MDA content increased, and the 
oxidative stress of the body was increased. According to 
the single factor variance analysis (P <0.05), the serum 
SOD activity of the sixth (negative control group) and 
the tenth groups (positive control group) and those of the 
seventh, eighth and ninth groups were significantly 
difference. 
Based on the above data, it was found that the presence 
of titanium dioxide had a certain effect on the free 
radical scavenging and detoxification of lung tissue, and 
the oxidative and antioxidant levels of the organism 
were stimulated by medium and high concentration 
exposure with a greater degree of damage to the body in 
the oxidative stress state (P <0.05). The SOD activity in 
the lung tissue of the seventh, eighth and ninth groups 
was significantly higher than that in the negative control 
group (sixth group) and positive control group (tenth 
group) from the single factor analysis of variance 
difference. 
In addition, the data analysis in the case of titanium 
dioxide poisoning showed the lung tissue cells by free 
radical attack for the ninth group significantly enhanced 
the body lipid peroxidation rate and intensity (P <0.05). 
The content of MDA in the lung tissue of the seventh, 
eighth and ninth groups were compared with the sixth 
group (negative control group) and the tenth group 
(positive control group) and showed a significant 
difference. 
4. DISCUSSION 
Nanotechnology is one of the three main pillars of 
technology in the 21st century, and is a hot topic of 
global debate. With the development of nanotechnology, 
nano-sized materials with a small scale, special structure 
and physicochemical properties have been applied in a 
variety of fields. Currently, more than 1,000 consumer 
products, identified as nanotechnology-dependent, are 
being used in the market, so experts are increasingly 
aware of the significance of a comprehensive assessment 
of nanomaterial safety and understanding the biological 
effects. However, with the wide application of 
nanomaterials, people are increasingly exposed to 
nanomaterials that may enter the body through various 
ways, such as: breathing, skin, injection, and being 
ingested. Many nanomaterials are not toxic by 
themselves, but can become toxic by altering their 
physical and chemical properties, such as particle size, 
shape, surface modification and the charge, composition, 
stability, solubility, and so forth. Zhang and co-workers 
have reported that iron oxide nanoparticles (IONPs) with 
a size of 10 mm predominantly accumulate in the liver 
whereas IONPs with a size of 40 mm were more 
concentrated in the spleen while the smaller IONPs (10 
mm) were more likely to alter the expression level of a 
gene 
[8]
. Compared with ZnO nanoparticles, rod-like 
ZnO NPs are more likely to result in toxic effects 
[9]
. 
Group Number of mice SOD（u/ml） MDA(nmol/mgprot) 
Six Group (Negative control group) 10 254.17±41.83 7.70±1.03 
Seventh group（Low concentration group） 10 241.02±38.01 7.52±1.84 
Eight group（Medium concentration group） 10 200.76±29.91 8.57±1.32 
The ninth group（High concentration group） 10 179.38±33.07 9.192±1.47 
Tenth group（Positive control group） 10 196.64±29.77 10.61±3.04 
P  P＜0.05 P＜0.05 
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TiO2 NPs have been shown to become part of the toxic 
substances carrier to effectively increase the biological 
toxicity of the original Cd
 [10]
. Therefore, it is very 
important to study the safety of nanomaterials and 
establish a safety detection system for nanomaterials. 
Currently, studies on the biosafety of TiO2 and the 
impact on the surrounding environment are gradually 
emerging, and the safety problems have been shown to 
mostly arise from oxidative stress or the generation of 
free radicals. Oxidative stress or free radicals can cause 
lipid peroxidation damage, and cause cell membrane 
damage, thereby resulting in cell apoptosis or death. The 
results show that, owing to the nanomaterials exhibiting 
a small size effect and huge surface area, nanomaterials 
are able to penetrate the cell tissue and exhibit a strong 
oxidation and catalytic capacity. Therefore, this study 
first considers the mechanism of oxidative stress and its 
role in the relevant principles of the organism. MDA is 
one of the most representative products of lipid 
peroxidation, and its content can predict the rate and 
intensity of lipid peroxidation, but also indirectly reflects 
the free radicals attack on the body cells and degree of 
damage. Additionally, SOD is involved in the 
intracellular free radical scavenging detoxification 
process, which can convert free radicals into H2O2. For 
oxidation in the body, SOD is an active substance that 
can be eliminated from the body by the metabolism of 
free radicals and other harmful substances generated by 
the body through oxygen free radical attack and will 
inevitably lead to increased peroxide which will then 
consume the excessive SOD. Hence, its activity can 
reflect the body's oxidative stress and the strength of the 
antioxidant capacity. In this study, we found that the 
MDA content in the experimental group increased 
significantly and the activity of SOD decreased 
significantly with an increase of the concentration of 
nano-TiO2. The oxidative and antioxidant levels of the 
nanostructured materials were greatly impaired and the 
free radicals were attacked. Additionally, lipid 
peroxidation increased significantly. Therefore, it is 
possible to explore the principle and method to establish 
the biosafety of the nanometre titanium dioxide material 
through the oxidative stress pathway. 
Our research on the biosafety of titanium dioxide 
nanomaterials is based on the principle of the oxidative 
stress experiment. Through the different routes of 
administration by tail vein and tracheal exposure, we set 
up different concentrations of the experimental groups 
and the negative and positive control groups. We 
analysed the data obtained by collecting SOD, MDA in 
serum and lung tissue (in vivo) and by comparing the 
different hypersensitive reactions (in vitro). In the tail 
vein administration experiment, the reaction rate and 
reaction degree of the allergy test showed that the higher 
the concentration, the higher the reaction degree and the 
higher the reaction rate. The SOD activity of the 
experimental group decreased, and the greater the SOD 
activity decreased, the greater the degree of its oxidative 
stress. In the experiment of tracheal exposure, the 
content of MDA in the serum of the high concentration 
group (group 9) was significantly higher than that of the 
control group (P <0.05), indicating that the 
concentration of titanium dioxide could cause the cells 
to be attacked by free radicals. The activity of SOD in 
groups 8 and 9 was significantly lower than that in group 
7, but there was no significant difference in the seventh 
group, which showed that the removal of free radicals 
and the detoxification process of lung cells had a certain 
effect under the condition of titanium dioxide exposure. 
The oxidative and antioxidant levels of the organism 
were damaged to a greater extent under the medium and 
high concentrations of exposure, so that the body was in 
an oxidative stress state. In the case of titanium dioxide 
exposure, lung tissue cells underwent free radical attack, 
and the ninth group resulted in the significantly 
enhanced the body lipid peroxidation rate and intensity. 
The above data show that the ninth group of lung tissue 
MDA was significantly increased compared with the 
seventh and eight groups, but there was no significant 
difference in the trend, indicating that in the case of 
titanium dioxide poisoning, lung tissue cells undergo 
free radical attacks, and for group 9, the rate and 
intensity of lipid peroxidation were significantly 
enhanced. In summary, the higher doses of titanium 
dioxide nanomaterial exposure will cause more serious 
oxidative damage to the body, resulting in a more severe 
oxidative stress response of the body, indicating that 
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direct exposure to higher doses of nanomaterials of 
titanium dioxide will result in a more severe toxicity. 
The study for the establishment of a nanomaterial safety 
system is of great significance. We have chosen a 
method which has a wide range of applications to 
titanium dioxide nanomaterials for research to obtain a 
safety system for nanomaterials. In a series of 
experiments, it was concluded that the higher the dose of 
nanomaterial titania from a direct exposure route would 
result in a more serious toxicity to the organism, thus 
laying a solid foundation for the future exploration of the 
safety system of TiO2 nanomaterials. However, in this 
experiment, a threshold of toxic concentration of TiO2 
nanomaterials was not obtained, and it is expected that 
this will be determined from future experiments, 
enriching the relevant conclusions of the establishment 
of the safety system of TiO2 nanomaterials. 
5. CONCLUSION 
Higher doses of a nano-titanium dioxide aqueous 
solution will cause more serious oxidative damage in 
mice, resulting in a more severe oxidative stress 
response, indicating that direct exposure to higher doses 
of nano-titanium dioxide produces a greater toxicity. 
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